Fatality

ASSP takes position opposing exploitative child labor

Retrieved on: 
Tuesday, April 2, 2024
Health, Learning, Environment, United, ASSP, ESG, United Nations, Child, Society, International Labour Organization, Workforce, CIH, Injury, Language, CSP, ANSI, Fatality, Toy

The statement from the board of directors declares that ASSP opposes all forms of exploitative child labor and calls on governmental and nongovernmental entities to combat such practices in the U.S. and worldwide.

Key Points: 
  • The statement from the board of directors declares that ASSP opposes all forms of exploitative child labor and calls on governmental and nongovernmental entities to combat such practices in the U.S. and worldwide.
  • “There has been a focus to loosen U.S. child labor laws to help industry combat labor shortages,” Thornton said.
  • With its child labor position set, ASSP will now pursue next steps that include:
    Publishing articles and hosting webinars to educate the occupational safety and health community.
  • Working with other occupational safety and health organizations to help prohibit exploitative child labor.

Westray Law 20th anniversary: ‘A historic failure’

Retrieved on: 
Friday, March 29, 2024
CLC, Westray Mine, Failure, Health, Congress, Criminal code, Memory, United Steelworkers, Police, Death, Parliament, USW, Survivor, The Criminal Code, Injury, Miner, Fatality, Law

“The overwhelming majority of these workplace fatalities and injuries were preventable, yet the Westray Law has rarely been used to prosecute employers and hold them criminally accountable.

Key Points: 
  • “The overwhelming majority of these workplace fatalities and injuries were preventable, yet the Westray Law has rarely been used to prosecute employers and hold them criminally accountable.
  • The Westray Law was named in memory of 26 coal miners who were killed in the Westray Mine explosion in Nova Scotia in 1992.
  • “The Westray Law was a historic achievement that promised greater corporate accountability for workplace safety and greater protection for workers,” says Allen Martin, whose brother Glenn, 35, was one of the miners killed in the Westray Mine explosion.
  • On the Westray Law’s 20th anniversary, the USW, supported by the CLC and other labour federations, is ramping up the campaign to pressure governments to take action to address the failure to enforce the law.

Peninsula: A Fully Protected Business Starts With SafeCheck

Retrieved on: 
Monday, April 8, 2024
Legal, Technology, Human Resources, Business, Professional Services, Software, Other Health, Health, General Health, Depression, Work, Major, Anxiety, Grenfell Tower, Life, Accident, Workplace, Occupational safety and health, Legislation, Fatality, Health insurance

A staggering number, of which:

Key Points: 
  • A staggering number, of which:
    875,000 suffer from work-related stress, depression, or anxiety
    Stephen Galley, SafeCheck Director at Peninsula, says, “Working in health & safety for the last 20 years, I’ve heard all the jokes.
  • So, not only does it make moral and ethical sense for a business to know their risks, it also makes financial sense too.
  • “The first priority for any responsible owner is to know where their business stands right now.
  • “95% of employers have five critical Health & Safety hazards in their business – are you one of them?

Combatting Texting and Driving in Nashville: Dolinsky Law Group Shares Safety Tips and Legal Consequences

Retrieved on: 
Tuesday, April 9, 2024
Education, GPS, Death, Insurance, Accident, Safety, Music, Injury, Fatality, Mobile phone

NASHVILLE, Tenn., April 9, 2024 /PRNewswire-PRWeb/ -- In response to the persistent issue of texting and driving, Dolinsky Law Group emphasizes the critical importance of road safety through the provision of essential safety tips and clarification of the legal consequences associated with distracted driving. This effort is part of the firm's ongoing commitment to promoting safer driving practices and preventing accidents linked to the use of mobile phones behind the wheel.

Key Points: 
  • Dolinsky Law Group emphasizes road safety by providing essential tips and outlining legal consequences to combat texting and driving in Nashville.
  • NASHVILLE, Tenn., April 9, 2024 /PRNewswire-PRWeb/ -- In response to the persistent issue of texting and driving, Dolinsky Law Group emphasizes the critical importance of road safety through the provision of essential safety tips and clarification of the legal consequences associated with distracted driving.
  • For those affected by distracted driving incidents, Dolinsky Law Group offers comprehensive legal support, from navigating insurance claims to pursuing compensation for injuries and losses.
  • For more information on avoiding texting and driving or to seek legal assistance, please contact Dolinsky Law Group at (800) 474-4089 or visit https://www.duejustice.com .

Fall Protection Equipment Market Projected to Reach $4.47 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Tuesday, April 9, 2024
Honeywell, 3M, Emergency, Culture, Growth, MSA, MSA Safety, Incidence, Safety, Intelligence, Risk, Accident, OSHA, Workplace, Fall protection, Workforce, Telecommunications, Occupational safety and health, Table, Fatality, Construction

With the implementation of stringent safety regulations worldwide and a growing awareness of occupational safety, there's a pressing demand for advanced fall protection solutions.

Key Points: 
  • With the implementation of stringent safety regulations worldwide and a growing awareness of occupational safety, there's a pressing demand for advanced fall protection solutions.
  • The key players in the Fall Protection Equipment Market include Honeywell International Inc., Delta Plus Group, MSA Safety Incorporated, 3M Company, WernerCo., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Fall Protection Equipment Market.
  • "Dive into the Fall Protection Equipment Market Landscape: Explore 189 Pages of Insights, 296 Tables, and 22 Figures"

Fall Protection Equipment Market Projected to Reach $4.47 billion by 2030 - Exclusive Report by 360iResearch

Retrieved on: 
Tuesday, April 9, 2024
Honeywell, 3M, Emergency, Culture, Growth, MSA, MSA Safety, Incidence, Safety, Intelligence, Risk, Accident, OSHA, Workplace, Fall protection, Workforce, Telecommunications, Occupational safety and health, Table, Fatality, Construction

With the implementation of stringent safety regulations worldwide and a growing awareness of occupational safety, there's a pressing demand for advanced fall protection solutions.

Key Points: 
  • With the implementation of stringent safety regulations worldwide and a growing awareness of occupational safety, there's a pressing demand for advanced fall protection solutions.
  • The key players in the Fall Protection Equipment Market include Honeywell International Inc., Delta Plus Group, MSA Safety Incorporated, 3M Company, WernerCo., and others.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Fall Protection Equipment Market.
  • "Dive into the Fall Protection Equipment Market Landscape: Explore 189 Pages of Insights, 296 Tables, and 22 Figures"

Equinor presents 2023 Integrated annual report

Retrieved on: 
Thursday, March 21, 2024
Annual report, Lindworm, Tax, Growth, Exchange, Snorre, Anders Opedal, GHG, Global warming potential, Gullfaks oil field, History, Acquisition, Security (finance), CCS, Nature, Carbon, Disclosure, Bank statement, Accident, Publication, CO2, Kilowatt-hour, Energy, ASA, Gina Krog, Use, Baugé, USD, NCS, Fatality, EQNR, Renewable energy

Equinor ASA (OSE: EQNR, NYSE: EQNR) publishes 2023 Integrated annual report, combining financial and sustainability reporting.

Key Points: 
  • Equinor ASA (OSE: EQNR, NYSE: EQNR) publishes 2023 Integrated annual report, combining financial and sustainability reporting.
  • The report for 2023 integrates the annual financial and sustainability reporting, reflecting the importance of sustainability for Equinor’s operational and financial performance, to our people, investors and other stakeholders.
  • The Equinor 2023 Annual Report on Form 20-F may be downloaded from Equinor's website at www.equinor.com.
  • See Use and reconciliation of non-GAAP financial measures in the integrated annual report for more details.

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

Retrieved on: 
Wednesday, March 13, 2024
Catalyst Pharmaceuticals, Steroid, Caregiver, Patient, Ageing, Duchenne muscular dystrophy, Hope, Fatality, Quality of life, Respiratory failure, Behavior, Vamorolone, FDA, DMD, Muscular dystrophy, Food, Pharmaceutical industry

CORAL GABLES, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced the U.S. commercial launch of AGAMREE® (vamorolone) oral suspension 40 mg/mL for the treatment of Duchenne Muscular Dystrophy ("DMD") in patients aged two years and older. Following the U.S. Food and Drug Administration ("FDA") approval on October 26, 2023, AGAMREE is now available by prescription and dispensed throughout the United States through a specialty pharmacy network.

Key Points: 
  • "Today, we proudly announced the U.S. commercial availability of AGAMREE, an innovative alternative steroid treatment for Duchenne Muscular Dystrophy.
  • Our Catalyst Pathways, a personalized program, is readily available to assist Duchenne Muscular Dystrophy patients and their families with the one‐on‐one education and financial support they need, thereby enhancing the access and affordability of AGAMREE for every patient.
  • For more information, caregivers and healthcare professionals can call 1-833-422-8259 or visit the Catalyst Pathways® website at www.yourcatalystpathways.com .
  • Duchenne Muscular Dystrophy, DMD, the most common form of muscular dystrophy, is a rare and life-threatening neuromuscular disorder characterized by progressive muscle dysfunction, ultimately leading to loss of ambulation, respiratory failure, and fatality.

ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors

Retrieved on: 
Saturday, April 6, 2024
Research, Women, FDA, Clinical Trials, Biotechnology, Pharmaceutical, Consumer, Health, Science, Oncology, Orbis, Urinary tract infection, Cardiac arrest, Stomatitis, Patient, Stroke, Lung cancer, University, Acute kidney injury, Neoplasm, Therapy, Anemia, Vomiting, Pleural effusion, Cellulitis, Shock (mechanics), Periodic breathing, Colorectal cancer, Abdominal pain, Safety, Immunohistochemistry, Fatigue, ADC, Daiichi Sankyo, Food, IHC, Sepsis, NSCLC, Appetite, Biliary tract, Constipation, NCCN, MD, Priority review, Fatality, Pneumonitis, HER2, ILD, Medication, Pneumonia, AstraZeneca, COVID-19, Biomarker, Diarrhea, Bleeding, MD Anderson Cancer Center, Nausea, Upper respiratory tract infection, Pharmaceutical industry

The first tumor agnostic approval of a HER2 directed therapy and ADC was based on efficacy data in 192 adult patients with previously treated unresectable or metastatic HER2 positive (IHC 3+) solid tumors who were enrolled in one of three multicenter phase 2 trials from the DESTINY clinical development program, including DESTINY-PanTumor02 , DESTINY-Lung01 or DESTINY-CRC02 .

Key Points: 
  • The first tumor agnostic approval of a HER2 directed therapy and ADC was based on efficacy data in 192 adult patients with previously treated unresectable or metastatic HER2 positive (IHC 3+) solid tumors who were enrolled in one of three multicenter phase 2 trials from the DESTINY clinical development program, including DESTINY-PanTumor02 , DESTINY-Lung01 or DESTINY-CRC02 .
  • In DESTINY-PanTumor02, efficacy was assessed in a subgroup of previously treated patients (n=111) with centrally or locally assessed HER2 positive (IHC 3+) solid tumors including either biliary tract, bladder, cervical, endometrial, ovarian, pancreatic or other tumors.
  • In DESTINY-Lung01, efficacy was assessed in a subgroup of patients (n=17) with centrally confirmed HER2 positive (IHC 3+) non-small cell lung cancer (NSCLC).
  • In DESTINY-CRC02, efficacy was assessed in the subgroup of patients (n=64) with centrally confirmed HER2 positive (IHC 3+) colorectal cancer.

Distracted Driving Fell 4.5% in 2023, Preventing An Estimated 55,000 Crashes and 250 Fatalities

Retrieved on: 
Thursday, April 4, 2024
Technology, Automotive, Trucking, Vehicle Technology, IOT (Internet of Things), Security, Transport, Telecommunications, Software, Other Automotive, Networks, Mobile, Wireless, EV, Electric Vehicles, Performance & Special Interest, Autonomous Driving, Vehicles, Fleet Management, Artificial Intelligence, Annual report, Smartphone, Risk, Crash, UBI, Research, Telematics, Insurance, Marketing, CMT, Distracted driving, Safety, Injury, Fatality, IIHS, Mobile phone

The report evaluates the various factors that can reduce distracted driving, including consent-driven usage-based insurance (UBI) programs, hands-free legislation, and increased media coverage of the dangers of distracted driving.

Key Points: 
  • The report evaluates the various factors that can reduce distracted driving, including consent-driven usage-based insurance (UBI) programs, hands-free legislation, and increased media coverage of the dangers of distracted driving.
  • *
    While a 4.5% reduction in distracted driving over the last year is an improvement, distracted driving is still dangerously high in the United States.
  • For the first time, CMT has published data on how the different types of distracted driving affect the impact speed of a crash.
  • The four states that introduced hands-free laws, where it’s illegal for people to handle their phones while driving, reduced distracted driving by an average of 7.1% and prevented an estimated 8,200 crashes and 37 fatalities in 2023.